L-dopa
The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.
... Dopamine neurotransmission influences approach toward rewards and reward-related cues. The best cited interpretation of this effect proposes that dopamine mediates the pleasure that commonly accompanies reward. This ...
6
Development of validated RP-HPLC method for the estimation of L-Dopa from Mucuna pruriens, its extracts and in Aphrodisiac formulation.
... A validated method has been developed for the estimation of L-Dopa in Capsule dosage form. Proposed method is simple, accurate and precise. The method is suitable for routine analysis of ...
6
Síntese e caracterização de complexos de Co(II) e Ni(II) com l-dopa, carbidopa e benzimidazol
... foram sintetizados por adição estequiométrica do ligante nas respectivas soluções de cloretos do metal. A coordenação ocorreu após a secagem dos solventes sob temperatura ambiente. A caracterização e proposta das ...
82
From L-dopa to dihydroxyphenylacetaldehyde: a toxic biochemical pathway plays a vital physiological function in insects.
... of L-dopa has been converted to DHPAA, progressive decay of the product was ...and L-dopa reaction mixtures, accumulation of DHPAA was decreased noticeably ...
11
The role of L-DOPA on melanization and mycelial production in Malassezia furfur.
... as L-DOPA, in order to synthesize melanin. L-DOPA also triggered hyphal formation in vitro when combined with kojic acid, a tyrosinase inhibitor, in a dose-dependent ...respect, ...
12
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure.
... chronic L-dopa treatment. Chronic L-dopa treatment is associated with L-dopa induced dyskinesia ...acute L-dopa treatment that the first ever administration alone ...
17
CRESCIMENTO E LIGNIFICAÇÃO DE RAÍZES DE MILHO SOB AÇÃO DE L-DOPA (L-3,4-DIIDROXIFENILALANINA)
... Mucuna pruriens (L.) DC. var. utilis é um exemplo de planta de cobertura do solo bem sucedida e com vários produtos naturais altamente ativos. Mucuna tem sido amplamente cultivada em áreas tropicais como ...
13
Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease.
... In order to enable the study of dynorphin metabolites with MALDI IMS, the brains were removed 60 minutes after the last L- DOPA injection. Several peaks from dynorphin metabolic fragments displayed ...
12
L-DOPA is an endogenous ligand for OA1.
... Measurement of cAMP. Cells were pretreated with forskolin (15 min) and then challenged with L -DOPA using an assay setup as previously described [47]. After 1 min of ligand exposure, cells were scraped into ...
9
Síndrome de Parkinson e L-dopa.
... Pe- quenas doses de vitamina B<; podem reduzir ou abolir por completo a ação da L-Dopa; esse fenômeno se verificou em um dos casos, no qual fizemos asso- ciação da L-Dopa com essa vi[r] ...
10
L-dopa, biperideno e excreção sebácea na doença de Parkinson.
... Entretanto, ainda em relação ao sexo feminino, observou-se que parkinsonianos com idade ^ 60 anos, sob terapêutica crônica, apresentam maior grau de excreção sebácea, diferindo signifi[r] ...
8
Tratamento da síndrome parkinsoniana pelo L-dopa.
... Quanto à escrita, a melhora global foi inexpressiva (7,0%) sendo que nos casos moderados atingiu 10%. Repercussões laboratoriais — Na análise dos resultados laboratoriais, lançamos os[r] ...
9
Tratamento do parkinsonismo com L-Dopa.
... São descritos efeitos cola- terais como náuseas, vômitos, anorexia, hipotensão ortostática, arritmias cardíacas, cefaléias, hipercinesias córeo-atetóticas, agitação, insónia e distúr- b[r] ...
6
Doença de Segawa: distonia progressiva sensível à L-dopa. Relato de caso.
... A prima da doente (ES, 70 anos), diagnosticada como tendo PSL, rela- tava início da sintomatologia aos 13 anos de idade; evoluiu lenta e progressivamente até a paraplegia espástica crur[r] ...
5
MATERIALS AND METHODS Microorganism
... 4-dihydroxyphenyl L-alanine) is an amino acid analogue, isolated from various plant sources but not found in the animal ...of L-DOPA, which is a precursor of dopamine as the former can transverse the ...
9
Arq. NeuroPsiquiatr. vol.65 número4B
... of L-dopa/carbidopa ...of L-dopa/car- bidopa was then increased (100/25mg per day), but she de- veloped erratic myoclonic jerks affecting upper muscle limbs and trunk and a better result was ...
4
Annona cherimolia as source of potential
... aromatic L-amino acid decarboxylase (AADC) activities were inhibited by 10 µM liriodenine to 20-70% and 10-14% of control levels at 3-12 h, respectively; TH activity was more influenced than AADC ...reduced ...
6
Bioinspired polyethersulfone-based hollow fiber membranes as the scaffolds in renal assist device for protein-bound toxins removal from blood
... Such assumptions in the above are supported by the literature data available on the polydopamine coatings. In fact from the recent studies provided by the different authors [79,84,104] it can be estimated that the ...
70
Mucuna pruriens (Velvet bean) rescues motor, olfactory, mitochondrial and synaptic impairment in PINK1B9 Drosophila melanogaster genetic model of Parkinson's disease.
... complex I deficiency [24] [32] has been characterized as a mechanism of energy balance failure [33] resulting also in dramatic loss of dopaminergic neurons [34]. Although in the present study we did not attempt any ...
11
Arq. NeuroPsiquiatr. vol.74 número4
... with L-dopa ...diagnosed, L-dopa naïve patients and their muscular performance in relation to the variable of work and ...to L-dopa ...
6